TeraImmune
Gaithersburg
About TeraImmune
TeraImmune is a developer of cell therapeutics created for autoimmune diseases and immune-related disorders. The company uses regulatory T (Treg) cells from a donor and makes Treg cells for hemophilia, multiple sclerosis, and graft-versus-host disease from stem cell transplantation, enabling the healthcare industry to suppress the unwanted immune reactions without side effects in patients with autoimmune diseases.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.0M
- Funding stage: M&A
- Last round: Debt Financing (Dec 2022)
- Website: teraimmune.com
- Phone: 301-232-4105
Industries & Categories
Biotechnology, Genetics, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/teraimmune-28704 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.